Premium
Spectrum of mucocutaneous manifestations in 277 patients with joint hypermobility syndrome/Ehlers‐Danlos syndrome, hypermobility type
Author(s) -
Castori Marco,
Dordoni Chiara,
Morlino Silvia,
Sperduti Isabella,
Ritelli Marco,
Valiante Michele,
Chiarelli Nicola,
Zanca Arianna,
Celletti Claudia,
Venturini Marina,
Camerota Filippo,
CalzavaraPinton Piergiacomo,
Grammatico Paola,
Colombi Marina
Publication year - 2015
Publication title -
american journal of medical genetics part c: seminars in medical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.419
H-Index - 101
eISSN - 1552-4876
pISSN - 1552-4868
DOI - 10.1002/ajmg.c.31425
Subject(s) - joint hypermobility , mucocutaneous zone , ehlers–danlos syndrome , medicine , hypermobility (travel) , dermatology , multivariate analysis , disease , physical therapy
Cutaneous manifestations are a diagnostic criterion of Ehlers–Danlos syndrome, hypermobility type (EDS‐HT) and joint hypermobility syndrome (JHS). These two conditions, originally considered different disorders, are now accepted as clinically indistinguishable and often segregate as a single‐familial trait. EDS‐HT and JHS are still exclusion diagnoses not supported by any specific laboratory test. Accuracy of clinical diagnosis is, therefore, crucial for appropriate patients' classification and management, but it is actually hampered by the low consistency of many applied criteria including the cutaneous one. We report on mucocutaneous findings in 277 patients with JHS/EDS‐HT with both sexes and various ages. Sixteen objective and five anamnestic items were selected and ascertained in two specialized outpatient clinics. Feature rates were compared by sex and age by a series of statistical tools. Data were also used for a multivariate correspondence analysis with the attempt to identify non‐causal associations of features depicting recognizable phenotypic clusters. Our findings identified a few differences between sexes and thus indicated an attenuated sexual dimorphism for mucocutaneous features in JHS/EDS‐HT. Ten features showed significantly distinct rates at different ages and this evidence corroborated the concept of an evolving phenotype in JHS/EDS‐HT also affecting the skin. Multivariate correspondence analysis identified three relatively discrete phenotypic profiles, which may represent the cutaneous counterparts of the three disease phases previously proposed for JHS/EDS‐HT. These findings could be used for revising the cutaneous criterion in a future consensus for the clinical diagnosis of JHS/EDS‐HT. © 2015 Wiley Periodicals, Inc.